<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>From January 1983 to December 1986 seventy-six previously untreated children with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) were treated by combination chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients were ineligible </plain></SENT>
<SENT sid="2" pm="."><plain>The treatment regimens include intermittent chemotherapy and for non-localized patients, prophylactic central <z:mp ids='MP_0008912'>nervous</z:mp> system chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>Intrathoracic non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients also had cranial prophylactic radiotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>Sixty-six patients (86.8%) achieved complete remission </plain></SENT>
<SENT sid="5" pm="."><plain>Two year failure-free survival rate was 82.1% for localized (stage I and II) NHL and 53.3% for non-localized (stage III and IV) NHL patients </plain></SENT>
<SENT sid="6" pm="."><plain>Failure-free survival did not differ significantly for the two major histologic diagnoses, but two year survival rate was lower in diffuse poorly differentiated lymphoblastic than undifferentiated non-Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (50% versus 66.8% respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Failure-free survival rate was 53.7% in <z:e sem="disease" ids="C0025061" disease_type="Disease or Syndrome" abbrv="">mediastinal disease</z:e> and, 73.2% in abdominal disease at 24 months </plain></SENT>
<SENT sid="8" pm="."><plain>Relapse rate was higher in mediastinal cases (46.1%) than primary abdominal cases (24.3%) at 24 months </plain></SENT>
<SENT sid="9" pm="."><plain>Eleven (13.5%) died of treatment related <z:hpo ids='HP_0100806'>sepsis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Although the overall survival rate was 72.4% at 2 years we need novel or more intensive programmes for mediastinal and non-<z:e sem="disease" ids="C0277565" disease_type="Disease or Syndrome" abbrv="">localized disease</z:e> </plain></SENT>
</text></document>